TRIBUNJATENG.COM – Medicine Sotrovimab Recently, it has gone viral because it is believed to be able to reduce the risk of death in Covid-19 patients.
The categories of patients most at risk are adults, pregnant women, and children under 12 years of age, who have mild to moderate symptoms.
Even the United Arab Emirates (UAE) has approved the use of the drug for Covid-19 patients who fall into the most at-risk category.
After going through a two-week evaluation phase and involving 6,175 patients, research shows that Sotrovimab able to prevent death by 100% and 99% effective in preventing patients from entering the intensive care unit, as reported by Arab News.
Health authorities under the Ministry of Health and Prevention (MoHAP) also stated that 97% of patients made a full recovery within 14 days.
Of the total patients studied, about 52% of them were 50 years or older, and almost all had diseases such as obesity, cancer, cardiovascular disease, and diabetes.
Sotrovimab is a monoclonal antibody drug that is administered intravenously.
This drug is manufactured by the global biopharmaceutical company GlaxoSmithKline.
MoHAP has approved the use of Sotrovimab after conducting a local evaluation.
It has also been approved for emergency use by the US Food and Drug Administration.
–
